Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease

2003 ◽  
Vol 188 (2) ◽  
pp. 0598-0598
Author(s):  
William J. Ledger
Keyword(s):  
Pelvic Inflammatory Disease ◽  
Inflammatory Disease ◽  
Outpatient Treatment ◽  
Treatment Strategies

Review on the Outpatient Treatment for Pelvic Inflammatory Disease, what is the best for Hong Kong?

2005 ◽  
Vol 12 (3) ◽  
pp. 162-167
Author(s):  
SW Kung ◽  
MH Ng
Keyword(s):  
Risk Factor ◽  
Hong Kong ◽  
Neisseria Gonorrhoeae ◽  
Disease Control ◽  
Pelvic Inflammatory Disease ◽  
Inflammatory Disease ◽  
Outpatient Treatment ◽  
Chronic Pelvic Pain ◽  
Treatment Guidelines ◽  
Control And Prevention

Pelvic inflammatory disease is an important risk factor for infertility, ectopic pregnancy and chronic pelvic pain. Although the Centers for Disease Control and Prevention published treatment guidelines for pelvic inflammatory disease in 2002, the effectiveness of treatment has been affected by the emergence of quinolone-resistant Neisseria gonorrhoeae. The prevalence of quinolone-resistant Neisseria gonorrhoeae is highly variable with time and place. In Hong Kong, quinolone-resistant Neisseria gonorrhoeae is over 90%, thus ceftriaxone, doxycycline and metronidazole should be the treatment of choice. For patients sensitive to cephalosporins, azithromycin and metronidazole can be considered as alternative treatments.

Multicenter Randomized Trial of Ofloxacin Versus Cefoxitin and Doxycycline in Outpatient Treatment of Pelvic Inflammatory Disease

1993 ◽  
Vol 86 (6) ◽  
pp. 604-610 ◽  
Author(s):  
MARK G. MARTENS ◽  
STEPHEN GORDON ◽  
DABNEY R. YARBOROUGH ◽  
SEBASTIAN FARO ◽  
DAVID BINDER ◽  
...  
Keyword(s):  
Randomized Trial ◽  
Pelvic Inflammatory Disease ◽  
Inflammatory Disease ◽  
Outpatient Treatment ◽  
Multicenter Randomized Trial
Sign in / Sign up

Export Citation Format

Share Document